- Marketwired•2 years agoHerborium Group, Inc. CEO Dr. Agnes P. Olszewski Ph.D., to Be Interviewed on Clear Channel - iHeart Business Talk Radio's "The Trader's Network" on January 17th, 2015
Herborium Group, Inc. , a novel Botanical Therapeutics® company focused on developing, licensing, and marketing of proprietary, botanical based medicines targeting unmet medical needs, announced today ...
We're sorry this is all we were able to find about this topic.
Herborium Group, Inc. (HBRM)
Other OTC - Other OTC Delayed Price. Currency in USD
|Day's Range||0.00 - 0.00|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||0.00|
|Avg Vol (3m)||125,000|
|Dividend & Yield||N/A (N/A)|